CardioGenics Holdings Inc

Equities

CGNH

US14160X2036

Medical Equipment, Supplies & Distribution

Market Closed - OTC Markets Other stock markets 03:59:49 2024-02-01 pm EST			5-day change	1st Jan Change
0.000001 ^USD	-.--%		-.--%	-.--%

2021	Cardiogenics Holdings Inc Announces A Record Date Change for Its Dividend Distribution	CI
2021	CardioGenics Holdings Inc. Announces License Agreement	CI

CardioGenics Holdings Inc Auditor Raises 'Going Concern' Doubt

January 30, 2012 at 05:27 pm EST

CardioGenics Holdings Inc filed its 10-K on Jan 30, 2012 for the period ending Oct 31, 2011. In this report its auditor, J.H. Cohn LLP, gave an unqualified opinion expressing doubt that the company can continue as a going concern.

Latest news about CardioGenics Holdings Inc

Cardiogenics Holdings Inc Announces A Record Date Change for Its Dividend Distribution	21-09-09	CI
CardioGenics Holdings Inc. Announces License Agreement	21-09-03	CI
CardioGenics Holdings Inc completed the acquisition of substantially all of the assets of Plasticap Inc.	15-11-01	CI
CardioGenics Holdings Inc entered into a non-binding letter of intent to acquire substantially all of the assets of Plasticap Inc.	15-10-04	CI
CardioGenics Holdings Inc. Appoints Karim Murabet as Director	15-01-12	CI
CardioGenics Holdings Inc Reports Earnings Results for the Third Quarter and Nine Months Ended July 31, 2013	13-09-27	CI
CardioGenics Holdings Inc Announces Commencement of Beta-Site Testing	13-08-21	CI
CardioGenics Holdings Inc Announces Internal Review Board Approval for Beta-Site Testing	13-06-05	CI
CardioGenics Holdings Inc announced that it has received $0.66 million in funding.	13-06-03	CI
CardioGenics Holdings Inc announced that it expects to receive $1.5 million in funding.	13-05-31	CI
CardioGenics Holdings Inc. Announces Demise of Director, Alexander D. G. Reid	13-02-28	CI
CardioGenics Holdings Inc. announced that it expects to receive $1 million in funding.	13-02-26	CI
CardioGenics Holdings Inc has Changed its Ticker to CGNH from CGNHE	12-04-17	CI
CardioGenics Holdings Inc will Change its Ticker to CGNH.E from CGNH	12-03-22	CI
CardioGenics Holdings Inc Announces Earnings Results for the Year Ended October 31, 2011	12-01-31	CI
CardioGenics Holdings Inc Auditor Raises 'Going Concern' Doubt	12-01-30	CI

Chart CardioGenics Holdings Inc

Duration

Period

More charts

Company Profile

CardioGenics Holdings Inc. is focused on technology and products targeting the immunoassay segment of the In-Vitro Diagnostic testing market. The Company has developed the QL Care Analyzer, a point-of-care immuno-analyzer, which is capable of running approximately 200+immunoassay diagnostic tests, such as cardiovascular diagnostic tests. As part of its technology, the Company has also developed a method for silver coating paramagnetic microspheres (a fundamental platform component of immunoassay equipment), which improves instrument sensitivity to light.

Sector

Medical Equipment, Supplies & Distribution

More about the company

Sector Diagnostic & Testing Substances

	1st Jan change	Capi.
CARDIOGENICS HOLDINGS INC	-.--%	142
BIOMÉRIEUX	-0.99%	12.62B
SHENZHEN NEW INDUSTRIES BIOMEDICAL ENGINEERING CO., LTD.	-9.59%	7.67B
DIASORIN S.P.A.	+2.25%	5.41B
AUTOBIO DIAGNOSTICS CO., LTD.	+0.02%	4.57B
10X GENOMICS, INC.	-51.89%	3.22B
ANDON HEALTH CO., LTD.	+6.42%	2.59B
VITROLIFE AB	-13.76%	2.05B
GUANGZHOU WONDFO BIOTECH CO.,LTD	-8.29%	1.79B
MYRIAD GENETICS, INC.	+1.67%	1.76B

Diagnostic & Testing Substances